182 related articles for article (PubMed ID: 34414938)
1. Effect of aspirin use on survival benefits of breast cancer patients: A meta-analysis.
Liu J; Zheng F; Yang M; Wu X; Liu A
Medicine (Baltimore); 2021 Aug; 100(33):e26870. PubMed ID: 34414938
[TBL] [Abstract][Full Text] [Related]
2. Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis.
Huang XZ; Gao P; Sun JX; Song YX; Tsai CC; Liu J; Chen XW; Chen P; Xu HM; Wang ZN
Cancer Causes Control; 2015 Apr; 26(4):589-600. PubMed ID: 25701248
[TBL] [Abstract][Full Text] [Related]
3. Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer.
McCarthy AM; Kumar NP; He W; Regan S; Welch M; Moy B; Iafrate AJ; Chan AT; Bardia A; Armstrong K
BMC Cancer; 2020 Apr; 20(1):347. PubMed ID: 32326897
[TBL] [Abstract][Full Text] [Related]
4. The Efficacy of Aspirin in Preventing the Recurrence of Colorectal Adenoma: a Renewed Meta-Analysis of Randomized Trials.
Zhao TY; Tu J; Wang Y; Cheng DW; Gao XK; Luo H; Yan BC; Xu XL; Zhang HL; Lu XJ; Wang YJ
Asian Pac J Cancer Prev; 2016; 17(5):2711-7. PubMed ID: 27268656
[TBL] [Abstract][Full Text] [Related]
5. Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.
Lin JL; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Huang CM
BMC Cancer; 2020 Jul; 20(1):638. PubMed ID: 32646396
[TBL] [Abstract][Full Text] [Related]
6. Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis.
Zhou Y; Simmons J; Jordan CD; Sonbol MB; Maihle N; Tang SC
Clin Breast Cancer; 2019 Oct; 19(5):354-362.e7. PubMed ID: 31262687
[TBL] [Abstract][Full Text] [Related]
7. Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study.
Fraser DM; Sullivan FM; Thompson AM; McCowan C
Br J Cancer; 2014 Jul; 111(3):623-7. PubMed ID: 24945997
[TBL] [Abstract][Full Text] [Related]
8. Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 2019.
Ma S; Guo C; Sun C; Han T; Zhang H; Qu G; Jiang Y; Zhou Q; Sun Y
Clin Breast Cancer; 2021 Dec; 21(6):552-565. PubMed ID: 33741292
[TBL] [Abstract][Full Text] [Related]
9. Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies.
Lahart IM; Metsios GS; Nevill AM; Carmichael AR
Acta Oncol; 2015 May; 54(5):635-54. PubMed ID: 25752971
[TBL] [Abstract][Full Text] [Related]
10. Aspirin intake and survival after breast cancer.
Holmes MD; Chen WY; Li L; Hertzmark E; Spiegelman D; Hankinson SE
J Clin Oncol; 2010 Mar; 28(9):1467-72. PubMed ID: 20159825
[TBL] [Abstract][Full Text] [Related]
11. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
12. Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants.
Lu L; Shi L; Zeng J; Wen Z
Oncotarget; 2017 Jun; 8(25):40389-40401. PubMed ID: 28418881
[TBL] [Abstract][Full Text] [Related]
13. Aspirin use and risk of breast cancer: systematic review and meta-analysis of observational studies.
Zhong S; Chen L; Zhang X; Yu D; Tang J; Zhao J
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1645-55. PubMed ID: 26315555
[TBL] [Abstract][Full Text] [Related]
14. Clinical evidence of the relationship between aspirin and breast cancer risk (review).
Jacobo-Herrera NJ; Pérez-Plasencia C; Camacho-Zavala E; González GF; Urrutia EL; García-Castillo V; Zentella-Dehesa A
Oncol Rep; 2014 Aug; 32(2):451. PubMed ID: 24927467
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Use and Survival Among Patients With Breast Cancer: A Systematic Review and Meta-Analysis.
Baker A; Kartsonaki C
Oncologist; 2024 Jan; 29(1):e1-e14. PubMed ID: 37358878
[TBL] [Abstract][Full Text] [Related]
16. Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005.
Mangiapane S; Blettner M; Schlattmann P
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):115-24. PubMed ID: 17955496
[TBL] [Abstract][Full Text] [Related]
17. Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.
Cronin-Fenton DP; Heide-Jørgensen U; Ahern TP; Lash TL; Christiansen P; Ejlertsen B; Sørensen HT
Epidemiology; 2016 Jul; 27(4):586-93. PubMed ID: 27007644
[TBL] [Abstract][Full Text] [Related]
18. Influence of postdiagnostic aspirin use on clinical outcomes of women with breast cancer: a meta-analysis.
Wu C; Hu M; Zhang S; Zhang J; Shen L; Shen X
Women Health; 2024 Feb; 64(2):94-108. PubMed ID: 38151762
[TBL] [Abstract][Full Text] [Related]
19. Aspirin and NSAIDs for breast cancer chemoprevention.
Yiannakopoulou ECh
Eur J Cancer Prev; 2015 Sep; 24(5):416-21. PubMed ID: 25380191
[TBL] [Abstract][Full Text] [Related]
20. Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.
McCowan C; Munro AJ; Donnan PT; Steele RJ
Eur J Cancer; 2013 Mar; 49(5):1049-57. PubMed ID: 23182687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
